Whistleblowers Assail Gilead's Escobar Defense At High Court
By Jeff Overley · March 5, 2018, 9:19 PM EST
Gilead Sciences Inc. is trying to escape a multibillion-dollar False Claims Act suit by wrongly asserting that the federal government clearly kept buying drugs despite knowledge of manufacturing violations, whistleblowers told...
To view the full article, register now.